Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK1562902A (H5N1) in Children 6-35 Months
NCT01323946Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2011
- Primary completion
- Jun 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated), sponsored by GSK. Started Apr 2011; status: completed.
02
Drugs
Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
Beyond the preview
Go deeper on NCT01323946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323946.